poisar

Stocks · News reference

Zevra Therapeutics Announces Publication Of "Long-Term Real-World Safety And Effectiveness Of Arimoclomol In Individuals With NPC: Outcomes From US Early Access Program Over A 4-Year Period" In Molecular Genetics And Metabolism

Aug 3, 2026, 11:34 AMBenzinga Newsdesk

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced the publication of

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ZVRA
Source
benzinga
Observed
Aug 3, 2026, 11:34 AM
Checked
Aug 3, 2026, 11:34 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading